Total medical devices industry venture financing deals in November 2020 worth $974.26m were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 17.1% over the previous month and a drop of 28.1% when compared with the last 12-month average, which stood at $1.36bn.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $717.85m. At the country level, the US topped the list in terms of deal value at $717.85m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The top country in terms of venture financing deals activity in November 2020 was the US with 31 deals, followed by China with 13 and the UK with four.
In 2020, as of the end of November 2020, medical devices venture financing deals worth $14.72bn were announced globally, marking an increase of 53% year on year.
Medical devices industry venture financing deals in November 2020: Top deals
The top five medical devices industry venture financing deals accounted for 41.1% of the overall value during November 2020.
The combined value of the top five medical devices venture financing deals stood at $400m, against the overall value of $974.26m recorded for the month.
The top five medical devices industry deals of November 2020 tracked by GlobalData were:
1) Hillhouse Capital Group, LYFE Capital, Orbimed Advisors and RA Capital Management’s $120m venture financing of Cytek Biosciences
2) The $100m venture financing of Carbon Health Medical Group by Brookfield Technology Partners II, Builders VC, DCVC Management Co and Dragoneer Investment Group
3) 3M Ventures, ARTIS Ventures, DigiTx Partners, Highland Capital Partners, NTT Venture Capital and Questa Capital Management’s $65m venture financing of Eko Devices
4) The $65m venture financing of AliveCor by Bold Capital Partners, Khosla Ventures, Omron Healthcare, Qualcomm Ventures and WP Global Partner
5) Cambridge Innovation Capital, Downing Ventures, Innovation Development Oman Holding SAOC, Legal & General Group, Parkwalk Advisors, Puhua Capital, Tencent Holdings and Xeraya Capital Sdn’s venture financing of Congenica for $50m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.